Type 2 diabetes duration associated with disease recurrence after gastric bypass

  • June 24, 2012

HOUSTON — Data from a retrospective analysis of patients who underwent Roux-en-Y gastric bypass surgery at the Mayo Clinic Arizona demonstrate that the rate of type 2 diabetes recurrence following the procedure was 21%. Additionally, duration of diabetes was linked to rate of recurrence after surgery.

“Patients with more than 5 years of type 2 diabetes prior to bariatric surgery were 3.8 times more likely to develop a recurrence of type 2 diabetes,” Yessica Ramos, MD, an internal medicine resident at Mayo Clinic Arizona in Scottsdale, said during a press conference.

The researchers identified 138 patients who underwent Roux-en-Y gastric bypass surgery between January 2000 and December 2007. Of these, 72 were included in their analysis and had a minimum of 3 years of continuous follow-up.

Ramos and colleagues aimed to determine the persistence, remission and re-emergence of type 2 diabetes after surgery. Remission was defined as HbA1c <6.5% with no pharmacological treatment; re-emergence was defined as HbA1c ≥6.5%, fasting glucose >7mmol/L or re-initiation of antidiabetic medications, according to the abstract.

Most patients (93%) were white, with a mean age of 49.5 years, and 54% were female. Preoperatively, mean BMI was 45 and mean duration of type 2 diabetes was 4.9 years. 

There were 66 patients in remission at a minimum of one time point, and six patients had persistent type 2 diabetes throughout follow-up. Of the 66 patients, 14 had recurrent type 2 diabetes: five patients developed disease 2 years after surgery, three at 3 years after, three at 4 years after and three at 5 years after. Additionally, duration of type 2 diabetes before Roux-en-Y surgery was significantly related to recurrence of disease (P=.0021).

“We ended up finding that one-fifth of the patients will develop diabetes after at least 3 years of follow-up, and up to 5 years of follow-up,” Ramos said.

The most relevant finding was that “the association included a long-standing history of diabetes,” she added.

The OR demonstrating that longer duration of preoperative type 2 diabetes was linked with a higher probability of recurrence was 1.26. According to Ramos, there was no significant association between pre-operative BMI or weight regain and a higher recurrence rate.

“Our conclusions were that the length of diabetes prior to bariatric surgery had a strong relationship to the re-emergence rate of diabetes. Early surgical intervention with type 2 diabetes patients who are obese may improve the durability of their remission of diabetes,” Ramos said. – by Stacey L. Fisher

For more information:

Ramos Y. Abstract #SAT-161. Presented at: the Endocrine Society’s 94th Annual Meeting & Expo; June 23-26, 2012; Houston.

Disclosure: The researchers report no relevant financial disclosures.

Perspective
  • I think the initial reports about how good gastric bypass is for diabetes need to be interpreted with a little caution because the underlying pathophysiology is still present, but there are some genetic components or lifestyle changes.

    You can still say that 86% of patients were still in remission after 5 years and only 14 patients went back to having type 2 diabetes; these results are pretty good, but surgery is not going to be a cure for everybody.

    • Theodore C. Friedman, MD, PhD
    • Chief, Division of Endocrinology, Metabolism and Molecular Medicine;
      Chairman, Department of Medicine;
      Professor of Medicine at Charles Drew University of Medicine and Science, and UCLA School of Medicine
  • Disclosures: Dr. Friedman reports no relevant financial disclosures.

Comments

Healio is intended for health care provider use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will Healio be used for medical advice to patients.